Details of the Target
General Information of Target
Target ID | LDTP02581 | |||||
---|---|---|---|---|---|---|
Target Name | Cholesteryl ester transfer protein (CETP) | |||||
Gene Name | CETP | |||||
Gene ID | 1071 | |||||
Synonyms |
Cholesteryl ester transfer protein; Lipid transfer protein I |
|||||
3D Structure | ||||||
Sequence |
MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDI
TGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTT AWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWI KQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVI TASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRL MLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSS VMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSE SVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGF PEHLLVDFLQSLS |
|||||
Target Type |
Clinical trial
|
|||||
Target Bioclass |
Transporter and channel
|
|||||
Family |
BPI/LBP/Plunc superfamily, BPI/LBP family
|
|||||
Subcellular location |
Secreted
|
|||||
Function |
Involved in the transfer of neutral lipids, including cholesteryl ester and triglyceride, among lipoprotein particles. Allows the net movement of cholesteryl ester from high density lipoproteins/HDL to triglyceride-rich very low density lipoproteins/VLDL, and the equimolar transport of triglyceride from VLDL to HDL. Regulates the reverse cholesterol transport, by which excess cholesterol is removed from peripheral tissues and returned to the liver for elimination.
|
|||||
TTD ID | ||||||
Uniprot ID | ||||||
DrugMap ID | ||||||
Ensemble ID | ||||||
HGNC ID | ||||||
ChEMBL ID |
Target Site Mutations in Different Cell Lines
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
BTD Probe Info |
![]() |
C350(5.48) | LDD1699 | [1] | |
NAIA_4 Probe Info |
![]() |
N.A. | LDD2226 | [2] |
Competitor(s) Related to This Target
The Interaction Atlas With This Target
The Drug(s) Related To This Target
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Anacetrapib | Small molecular drug | D07HLS | |||
Dalcetrapib | Small molecular drug | D05SSC | |||
Evacetrapib | Small molecular drug | D02XXN |
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Drl-17822 | . | D07UJA | |||
Jtt-302 | . | D04ZBU | |||
Ta-8995 | . | D0G7MM |
Phase 1
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Bay-60-5521 | . | D00JQE |
Preclinical
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Bay-38-1315 | Small molecular drug | D05QXT |
Investigative
Discontinued
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Cp-800569 | Small molecular drug | D03MAD | |||
Torcetrapib | Small molecular drug | D07GDN | |||
Ceti-1 | Vaccine | D0J4KC | |||
Ds-1442 | . | D0F8XI | |||
Pf-3185043 | . | D0K3GU | |||
R7232 | . | D0B0UN |
References